BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  VM BioPharma Announces Initiation of Hepatocyte Growth Factor to Improve Functioning in PAD, HI-PAD, Study of VM202 in Peripheral Artery Disease

  VM BioPharma today announced the launch of the HI-PAD study, a trial to investigate the effect of VM202, a DNA plasmid encoding HGF, on mobility and calf perfusion in older adults with PAD.

  December 1, 2017

   · 

  6 min read
• 

  Business

  Basilea Snags Extended $226M+ Antifungal Deal With Pfizer

  Basilea eligible to receive additional upfront and milestone payments of up to USD 226 million and mid-teen royalties on sales.

  December 1, 2017

   · 

  5 min read
• Pharm Country

  Tauriga Sciences Fully Repays $45,000 8% Face Value Convertible Debenture Issued to GS Capital Partners, LLC for One Time Cash Payment of $61,664.79

  This convertible debenture, which was issued by the Company on May 30, 2017, has been fully repaid for a one-time cash payment of $61,664.79 USD.

  December 1, 2017

   · 

  3 min read
• Polyganics Awarded €1.2 Million to Complete Clinical Development of Dura Sealant Patch

  The grant, together with contributions from the city and province of Groningen, totals EUR 1.2 million.

  December 1, 2017

   · 

  1 min read
• MBS Selects AMPLITECH to Launch NEXTGENPCR in France and Switzerland

  Described as the first real advance in thermal cycling for 15 years, the NEXTGENPCR dramatically slashes current time-consuming DNA amplification from hours to minutes.

  December 1, 2017

   · 

  2 min read
• Business

  Athenex Announces Planned Retirement of Chief Financial Officer Nick Riehle

  Mr. Riehle intends to retire from full time employment in order to spend more time with his family.

  December 1, 2017

   · 

  4 min read
• Business

  MMJ PhytoTech Ltd PhytoTech Therapeutics Ltd Management Changes

  MMJ PhytoTech wishes to advise that Dr Daphna Heffetz, CEO of the Company’s subsidiary PTL, has tendered her resignation.

  December 1, 2017

   · 

  1 min read
• Pharm Country

  Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety and Efficacy in Clinical Trials

  The new service enables the independent adjudication of clinical events in conformance with regulatory requirements governing clinical trials within all therapeutic areas, including cardiac studies and for MACE committees.

  December 1, 2017

   · 

  4 min read
• Policy

  Roche Supports FDA Communication About Potential for Biotin Interference With Lab Tests

  Roche supports the recommendation issued by the FDA that patients should report if they are taking biotin as a supplement to their health care providers as part of their patient profile

  December 1, 2017

   · 

  4 min read
• Biotech Bay

  NeuroPace Launches New RNS Tablet at 2017 American Epilepsy Society Annual Meeting

  The Tablet will be on display and available for use during hands-on workshops at the American Epilepsy Society’s (AES) Annual Meeting in Washington D.C. from December 1-5 at booth 1101.

  December 1, 2017

   · 

  3 min read